Sun, R.* ; He, L.* ; Lee, H.* ; Glinka, A.* ; Andrésen, C.* ; Hübschmann, D.* ; Jeremias, I. ; Müller-Decker, K.* ; Pabst, C.* ; Niehrs, C.*
RSPO2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia.
Cell Rep. 36:109559 (2021)
Acute myeloid leukemia (AML) is a rapidly progressing cancer, for which chemotherapy remains standard treatment and additional therapeutic targets are requisite. Here, we show that AML cells secrete the stem cell growth factor R-spondin 2 (RSPO2) to promote their self-renewal and prevent cell differentiation. Although RSPO2 is a well-known WNT agonist, we reveal that it maintains AML self-renewal WNT independently, by inhibiting BMP receptor signaling. Autocrine RSPO2 signaling is also required to prevent differentiation and to promote self-renewal in normal hematopoietic stem cells as well as primary AML cells. Comprehensive datamining reveals that RSPO2 expression is elevated in patients with AML of poor prognosis. Consistently, inhibiting RSPO2 prolongs survival in AML mouse xenograft models. Our study indicates that in AML, RSPO2 acts as an autocrine BMP antagonist to promote cancer cell renewal and may serve as a marker for poor prognosis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Acute Myeloid Leukemia ; Bmp ; Drug Resistance ; Hspc ; Leukemia Stem Cell ; Macrophages ; Monocytes ; R-spondin ; Self-renewal ; Wnt; Acute Myelogenous Leukemia; Hematopoietic Stem-cells; Wnt/beta-catenin; Wnt; Gene; Differentiation; Expression; Proteins; Cancer; Receptor
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 36,
Issue: 7,
Pages: ,
Article Number: 109559
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF-Topic(s)
30204 - Cell Programming and Repair
Research field(s)
Stem Cell and Neuroscience
PSP Element(s)
G-506600-001
Grants
Deutsche Forschungsgemeinschaft (DFG)
Max-Eder Grant of the German Cancer Aid
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-09-21